Radisens announces official start of the FerrTest project
Cork – Oct 01, 2020 – Radisens today announced the official start of the FerrTest project, in collaboration with its partners Irish Manufacturing Research, PolyPico Technologies Ltd. and Trinity College Dublin. Through the FerrTest project, Radisens aims to advance its dried reagent, microfluidic cartridge and reader technologies while developing scalable cartridge manufacturing processes for a quantitative, point-of-care ferritin (iron stores) test.
Ferritin is the principal storage protein for iron in cells and the concentration in plasma reflects the body’s iron stores. A low amount of plasma ferritin is an indicator of iron depletion. Current clinical measurement of ferritin is restricted to laboratory testing as no suitable quantitative point-of-care in vitro diagnostic solution exists. FerrTest is part of the Government’s Disruptive Technologies Innovation Fund (DTIF), with Radisens leading the consortium to develop a point-of-care ferritin platform for at-risk blood donors, women and children.Ferritin is the principal storage protein for iron in tissues and is involved in its uptake, accumulation and release in cells. Current clinical measurement of ferritin is restricted to laboratory testing as no suitable quantitative point-of-care in vitro diagnostic solution exists. The FerrTest project aims to both develop disruptive technologies and automated manufacturing processes for a quantitative point-of-care platform to measure ferritin.